Herpesviruses are characterized as having two distinct life cycle phases: l
ytic replication and latency. The mechanisms of latency establishment and m
aintenance, as well as the switch from latency to lytic replication, are po
orly understood. Human gammaherpesviruses, including Epstein-Barr virus (EB
V) and human herpesvirus-8 (HHV-8), also known as Kaposi's sarcoma-associat
ed herpesvirus (KSHV), are associated with lymphoproliferative diseases and
several human tumors, Unfortunately, the lack of cell lines to support eff
icient de novo product;ive infection and restricted host ranges of EBV and
HHV-8 make it difficult to explore certain important biological questions.
Murine gammaherpesvirus 68 (MHV-68, or gamma HV68) can establish de novo ly
tic infection in a variety of cell lines and is also able to infect laborat
ory mice, offering an ideal model with which to study various aspects of ga
mmaherpesvirus infection, Here we describe in vitro studies of the mechanis
ms of the switch from latency to lytic replication of MHV-68, An MHV-68 gen
e, rta (replication and transcription activator), encoded primarily by open
reading frame 50 (ORF50), is homologous to the rta genes of other gammaher
pesviruses, including HHV-8 and EBV, HHV-8 and EBV Rta have been shown to p
lay central roles in viral reactivation from latency. We first studied the
kinetics of HHV-68 rta gene transcription during de novo lytic infection. M
HV-68 rta was predominantly expressed as a 2-kb immediate-early transcript.
Sequence analysis of MHV-68 rta cDNA revealed that an 866-nucleotide intro
n 5' of ORF50 was removed to create the Rta ORF of 583 amino acids. To test
the functions of MHV-68 Rta in reactivation, a plasmid expressing Rta was
transfected into a latently infected cell line, S11E, which was established
from a B-cell lymphoma in an MHV-68-infected mouse. Rta induced expression
of viral early and late genes, lytic replication of viral DNA, and product
ion of infectious viral particles. We conclude that Rta alone is able to di
srupt latency, activate viral lytic replication, and drive the lytic cycle
to completion, This study indicates that MHV-68 provides a valuable model f
or investigating regulation of the balance between latency and lytic replic
ation in vitro and in vivo.